Conventus Orthopaedics Acquires Flower Orthopedics

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

Conventus Orthopaedics, Inc. has completed the acquisition of Flower Orthopedics, the market leader in Ready-for-Surgery™ single-use, sterile-packaged, implant and instrument kits. The news was announced today (May 27, 2020).

The state-of-the-art sterile FlowerCube™ system eliminates expensive set processing, which enables surgical facilities to complete back-to-back cases, enhance efficiencies, and maximize resources.  In addition to a robust fixation portfolio, Flower’s continuum of care also extends into the fast-growing wound care market for both orthopedic & podiatric surgeons.

Conventus Orthopaedics pioneered the platform nitinol CAGE technology to treat proximal humerus and distal radius fractures with unmatched stability & reduced complications compared to plating.  The Conventus lower extremity CAGE™ implant system is currently in development along with a new and innovative distal fibula intramedullary nailing system.  Both are expected to accelerate time to weight-bearing while reducing complications.

Rick Epstein, Chief Executive Officer of Conventus, commented, “Flower is an excellent strategic fit with Conventus.  With ongoing concerns over viral and infection risks associated with heavy reusable orthopedic implant trays, Flower’s Ready-for-Surgery™ platform reduces exposure to bioburden while enhancing OR efficiencies.  We will continue to develop and acquire innovative products and companies that improve procedures, patient outcomes and safety for orthopedic and foot & ankle surgeons.”

Andrew ElBardissi, MD, Partner at Deerfield Management stated that, “We are excited about the progress that Conventus has made over the past year. With the acquisition of Flower Orthopedics, we believe the company is positioned to be a leader in the development of innovative orthopedic technologies. We look forward to supporting the company’s continued growth.”

Conventus intends to continue to aggressively pursue new and innovative orthopedic technologies that are clinically relevant to surgeons, hospitals, and ambulatory surgery centers.

spot_img

DON'T MISS

Related Articles